Galectin Therapeutics Inc GALT
News
Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026
Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Galectin Therapeutics Shares Surge on Positive FDA Meeting, Phase 3 Trial Plans
Galectin Shares Fall After FDA Raises Issues With Belapectin Program

